Maxim Message Board - Msg: 13407263

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Maxim

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WTDEC who wrote (13)	4/12/2000 3:09:00 PM
From: biowa	Read Replies (1) of 24

Walter, So what did you think of the 24-week HCV data? siliconinvestor.com Looked pretty good, and the call sounded very promising. What's more, during the call they kept using the phrase from the PR, "These results are consistent with the positive results we have seen when using Maxamine in other clinical studies for indications such as malignant melanoma..." They also seemed to take a very aggressive stance that they believe that Maxamine will be shown to be an effective adjuvant for "many" types of immunotherapy. Since the PIII malignant melanoma results are to be released at ASCO in May, can we assume that they already have them in hand (believe they said as much on the call, something about being analyzed)? Thus, their tone would suggest that they are positive. The company also said in response to a question that an NDA filing in July would be an appropriate guess. This is a bear market... biowa

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next